Military families navigating the complexities of the Civilian Health and Medical Program of the Department of Veterans Affairs now have a wider path to mental health support. WellQor, a national online therapy provider, has officially integrated CHAMPVA into its insurance network to address chronic shortages in accessible care.
Toews Asset Management debuted its Agility Shares Hedged Risk ETF (HRSK) on the New York Stock Exchange on June 15, 2026. The fund, which pairs large-cap U.S. equity exposure with a dynamic hedging program, was seeded through a Section 351 exchange to provide immediate scale while offering tax-deferred asset transfers for eligible investors.
From the halls of the World Economic Forum to the Schatzalp, students aged 6 to 18 have turned high-level policy dialogues into a structured manifesto. The Rosenberg Youth Manifesto for Action, launching June 20, codifies resolutions on governance, education, and industry, demanding that leaders shift from abstract rhetoric to accountable implementation.
Palo Alto-based Sonire Therapeutics has secured approximately $13 million in non-dilutive funding from Japan’s New Energy and Industrial Technology Development Organization. The grant, awarded through the Deep-Tech Startups Support Program, aims to accelerate the global commercialization of the firm's non-invasive, ultrasound-guided HIFU platform for treating pancreatic cancer.
Texas-based OCuSOFT Inc. has launched Retaine® Ultra PF™, a preservative-free lubricant eye drop delivered in a multi-dose bottle. The product enters the market as an economical alternative for patients requiring long-term, non-preserved artificial tears, supplementing the company’s existing premium offerings for moderate to severe dry eye conditions.
A high-stakes training facility in Texas has become the first site for the commercial rollout of QuantrusX, an edge intelligence platform developed by RMX Industries. This transition marks the company’s shift from experimental development to active, real-world operation, aiming to provide instantaneous data interpretation and localized decision support.
Florida-based Base Molecular Resonance Technologies has unveiled its Generation 2 detection platform, claiming the ability to track nuclear signatures from hundreds of miles away. During a recent demonstration, the company reported tracking U-235 from Stuart, Florida, to a power plant in Texas, a distance of approximately 970 miles.
Tim Dougherty spent 36 months in federal prison, emerging at age 35 to face the systemic barriers that keep 75% of formerly incarcerated individuals unemployed. Today, he manages a wellness empire producing 50,000 meals weekly, turning a personal quest for discipline into a national franchise movement.
Investors who purchased ADMA Biologics securities between August 9, 2024, and March 25, 2026, have until August 10 to seek appointment as lead plaintiff in a class action lawsuit. Filed in the District of New Jersey, the case alleges the company misled shareholders regarding its revenue growth and internal controls.
VolitionRx has entered a strategic partnership with global diagnostics firm Sysmex to integrate its proprietary Nu.Q® NETs H3.1 assay into the Japanese company’s existing analyzer infrastructure. The collaboration targets the multibillion-dollar market for monitoring diseases linked to NETosis, including sepsis and various acute inflammatory conditions.
Basel-based FiberSense AG has cleared a significant regulatory hurdle, receiving CE marking under EU Regulation 2017/745 for its Class IIb continuous glucose monitoring system. This certification allows the company to transition from years of clinical development toward manufacturing scale-up and a commercial launch scheduled for late 2026.
A new urine-based test targeting microbially derived metabolites has entered the U.S. market, aiming to provide an objective biological tool for early autism risk assessment. Developed at Arizona State University, the screening platform seeks to supplement traditional behavioral observations for children aged two and older.
Divergent Technologies is scaling its domestic manufacturing footprint with the launch of the Monolith One, an advanced industrial metal 3D printer, and a new 430,000-square-foot factory in Long Beach, California. The expansion aims to boost annual production of critical hardware for the defense and aerospace sectors by an eightfold margin.
Rochester Midland Corporation has acquired Depew-based ClarityChem, integrating a three-decade veteran of industrial water treatment into its regional service network. The deal, announced June 17, brings ClarityChem’s specialized expertise in boiler systems, wastewater management, and odor control under the umbrella of the 138-year-old Rochester-based specialty chemical provider.
Consulting Solutions has appointed Robert Ziegler to the role of Chief Revenue Officer, tasking the veteran executive with overseeing the firm’s sales organization and expanding its market reach. The Jacksonville-based technology services provider aims to leverage his expertise to accelerate growth amid increasing demand for enterprise digital transformation.
A major expansion of refractive surgery capacity is underway as Aier Eye Hospital Group and ZEISS Medical Technology finalize a strategic agreement for 25 VISUMAX 800 femtosecond laser systems. The deal, signed June 12 in Changsha, signals a push to standardize high-precision surgical workflows across the hospital's global network.
A five-point climb in consumer affinity now translates to a ten percent revenue boost, according to a new diagnostic framework launched by Wpromote x Giant Spoon. The tool, dubbed the Care Index, aims to bridge the long-standing disconnect between creative brand-building exercises and bottom-line financial performance for retail marketers.
The Connectivity Standards Alliance opened its Unify event in Austin this week, marking a shift toward broader interoperability by unveiling Matter 1.6 and Product Security 1.1. The gathering signals a push to unify fragmented smart home ecosystems while formally welcoming ADT and Telink to the organization's board of directors.
Facing an inflection point in its clinical pipeline, Azitra CEO Francisco Salva announced a strategic reorientation that shifts the company’s focus toward cosmetic ingredients and high-value recombinant proteins. The move follows a $10.5 million capital raise in March, intended to prioritize programs with faster paths to commercialization.
Born in a decade of upheaval and shaped by years in the rural margins, Professor Ge Zhaoguang has spent his career dismantling the traditional center-focused narrative of Chinese identity. On June 17, the Tang Prize Foundation honored the Fudan University scholar with the 2026 Sinology award for his transformative research.
.png)
Flagright, a startup positioning itself as an AI-driven operating system for financial crime compliance, has closed a $12.5 million Series A round. Led by Infinity Ventures, the investment aims to bolster the company’s expansion into the U.S. market while accelerating the deployment of explainable AI tools for banking and fintech enterprises.
After more than a century under the Calandra family's direct leadership, Pittsburgh-based infrastructure supplier Jennmar has shifted its ownership structure. KPS Capital Partners has secured a majority equity stake in the company, a move that coincides with the appointment of Dave Webster as the new Chief Executive Officer.
At the 2026 American Society of Clinical Oncology annual meeting in Chicago, Jerusalem-based Nectin Therapeutics presented Phase 1a/1b results for its lead antibody candidate, NTX1088. The study evaluated the drug in combination with pembrolizumab, showing early signs of anti-tumor activity in patients with heavily pretreated, advanced solid tumors.
Acelen Renewables is tapping Honeywell’s modular Ecofining technology to accelerate the construction of a major biofuel refinery in Bahia, Brazil. By utilizing native macaúba oil as a sustainable feedstock, the site aims to address surging global demand for renewable diesel and sustainable aviation fuel through advanced automation and process integration.
Only 29% of organizations currently achieve significant returns on generative AI investments, according to the 2026 Enterprise AI Adoption Survey. To bridge this divide between strategy and production, Mission Cloud has unveiled a five-product suite designed to transition businesses from initial brainstorming to functional, AWS-native AI infrastructure.
Twenty-one physicians from Virginia Cancer Specialists have been inducted into the Washingtonian “Top Doctors” Hall of Fame. The designation honors medical professionals who have earned repeated recognition from their peers for consistent excellence in patient care and clinical leadership within the Northern Virginia medical community.
Amsted Automotive is pivoting its manufacturing strategy toward the European infrastructure sector, launching a new line of mining and road milling cutting tools at its Turin, Italy facility. This shift marks the company’s push to localize production for regional clients while leveraging 120 years of expertise in cold-forming metal technology.
Boulder-based Atom Computing and Cambridge startup Nu Quantum are joining forces to bridge the gap between experimental quantum machines and industrial utility. The two companies signed a Memorandum of Understanding to integrate neutral-atom processors with photonic networking hardware, aiming to create modular, fault-tolerant distributed systems.
Venture capital is suffering from a structural crisis defined by trapped capital and misaligned incentives. As the industry consolidates, the traditional decade-long lockup period has left founders and early backers without the liquidity they need, prompting experts to look toward blockchain as a necessary evolution for modern finance.
For years, scoliosis bracing was considered merely a defensive measure to prevent further spinal degradation. New clinical data presented at the 2026 SOSORT Congress in Turin, Italy, suggests a shift in perspective: with high-quality 3D bracing and rigorous monitoring, active spinal curve improvement is now a measurable goal.
